LND topic: tme page 344

tme

Pfizer's New Treatment for Hemophilia Gets FDA Approval

October 18, 2024

Pfizer Inc. has shared some exciting news! Their new medicine, HYMPAVZI (marstacimab-hncq), just got the green light from the U. S. Food and Drug Administration. This medication is designed to help people with hemophilia A and B prevent or reduce bleeding episodes. Hemophilia is a rare condition th

business

The Power Trio of AI Investing: Kutcher, Epstein, and Oseary at Disrupt 2024

October 18, 2024

Ever wondered who's banking on AI's bright future? Enter Ashton Kutcher, Effie Epstein, and Guy Oseary – the dream team behind Sound Ventures. This Beverly Hills-based firm turned heads last year with a whopping $265 million AI fund, targeting just six big-league companies like OpenAI and Hugging Fa

politics

Ukraine's Army Uses Ads to Attract New Recruits

October 18, 2024

In Ukraine, the military is using unique methods to attract new soldiers. For instance, a giant billboard in Kharkiv features a stylish woman with a gun, riding on a motorcycle with a soldier. This isn't your typical military recruitment ad; it's more like something you'd see for a new perfume. The

finance

Seeing Patterns: Why Some Stocks Can Feel Like a Bet

October 18, 2024

Investment strategist Doug Cohen from Fiduciary Trust International covered a lot of ground in a recent interview with Quartz. Talking about the volatile world of stocks, especially those related to Trump Media, he highlighted the speculative nature of such investments. How can you tell if a stock

politics

Texas AG Targets Dallas Doctor Over Teen Trans Care

October 18, 2024

Texas Attorney General Ken Paxton is making waves by suing a Dallas pediatrician, Dr. May Lau. He says she's breaking state law by giving hormone treatments to teens trying to transition their gender. Paxton claims these treatments are harmful and irreversible. The law he's using, SB 14, was passed

finance

Microsoft's Untapped Potential: A Turnaround Story

October 18, 2024

JR Research, a top analyst in the tech and software sectors, sees Microsoft as a promising investment opportunity. He focuses on finding growth stocks with strong potential and bargain prices. Microsoft, once a high-flyer, has taken a hit recently. But JR Research believes this could be a chance to

business

Microsoft's Upcoming Earnings: Expect the Unexpected

October 18, 2024

Ever wondered how the tech giant Microsoft is doing? Well, the latest buzz is all about their quarterly earnings report coming up soon. Experts like Daniel Sereda, who works for a family office investing across continents, are busy sifting through mountains of data to get a clear picture. Why shoul

finance

Microsoft: Time to Explore New Options

October 18, 2024

Have you ever heard the phrase, "Don't put all your eggs in one basket"? Well, that's exactly what some investors are starting to think about Microsoft (MSFT). Back in April 2024, when the stock was dropping from its high of $429. 37, some experts suggested that Microsoft might face some bumps in th

health

New Ways to Prevent HIV: Injectables vs. Pills

October 18, 2024

HIV prevention has come a long way. Safe sex practices, like using condoms and reducing partners, are still key. Surgical methods, like male circumcision, can also help. Treating infections is another preventive measure. But, people don't always use these methods. That's why scientists are exploring

finance

BlackRock's Big Move: Should You Invest?

October 18, 2024

Meet BlackRock, a giant in the financial world that's been making waves. The company, which manages over $11 trillion in assets, just crushed expectations with its latest quarterly earnings. CEO Larry Fink shared that the firm added a massive $2 trillion organically over the past five years, making